Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study

Frontiers When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy

Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases. - Abstract - Europe PMC

Diagnostics, Free Full-Text

The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderl

Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature, Journal of Ovarian Research

Borderline Epithelial Tumors of the Ovary

Anaplastic carcinoma showing rhabdoid features combined with ovarian mucinous borderline cystadenoma: a case report and literature review - Tingting Sun, Liming Tian, Yunyun Guo, Yu Zheng, Linglong Ouyang, Xianbin Zhang, Yingrong Lai

Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics, Diagnostic Pathology

Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor

A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary